Craig A Metz

Dr. Craig Metz has over 45 years of pharmaceutical industry experience and is a former Vice President of US Regulatory Affairs at GlaxoSmithKline, where he led the regulatory group responsible for GSK’s entire early drug development portfolio. In this capacity, Craig provided oversight and review for 60-80 initial IND submissions each year, many of which were in therapeutic settings involving rare disorders or orphan diseases with significant unmet medical need.